Latest Acute myeloid leukemia Stories
Presentations Including Pivotal Data on Kyprolis® and Blinatumomab, a BiTE® Immunotherapy, Demonstrate Company's Continued Commitment to Developing Treatments for Difficult-to-Treat Blood Cancers THOUSAND
BERGEN, Norway, November 4, 2014 /PRNewswire/ -- BerGenBio AS ("BerGenBio" or the "Company"), an oncology biopharmaceutical company, today announces that the first patient
Comprehensive Cancer Diagnostic Report to include clinical data, FDA approved therapies MILWAUKEE, Oct.
AMSTERDAM, October 30, 2014 /PRNewswire/ -- Kiadis Pharma B.V.
This Year Marks the 20th Anniversary of LLS's Prestigious Translational Research Program WHITE PLAINS, N.Y., Oct.
The Program is Jointly Funded by LLS and Janssen Research & Development, LLC WHITE PLAINS, N.Y., Oct.
- Tosedostat Currently in Phase 2 Development for Patients with AML and MDS - SEATTLE, Oct. 27, 2014 /PRNewswire/ -- CTI BioPharma Corp.
WHITE PLAINS, N.Y., Oct.
University of Pennsylvania and Children's Hospital of Philadelphia Research Team Funded by LLS for More Than 22 Years Report Today in New England Journal of Medicine that 90 Percent of Patients Achieved
Expansion of Collaboration Enables Identification of Optimal Patient Profiles and Combination Strategies for APTO-253 SAN DIEGO, CA AND TORONTO, ON; PORTLAND, OR AND WHITE PLAINS, NY,
- Large; stout; burly.